SID 2026Abstract 0274
Cutaneous adverse events of bispecific antibody talquetamab are associated with lower all-cause mortality in multiple myeloma
Corey S, Patil MK, Shi CR, Thompson B, Ma KS, Chen S
SID Annual Meeting 2026Chicago, 13–16 May 2026 · published in JID 21 Jul 2026
Topics: Drug reactions
Abstract
The abstract’s text is on the JID website.
DOI 10.1016/j.jid.2026.06.305 · Not in PubMed: details from Crossref